FUCHS HENRY J
SEC CIK 1197355 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Pres, Worldwide R, D | 185.1K | — | $4.10M | 14 | 2022-03-08 | 2024-09-13 |
Most active insiders at BMRN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis George Eric | EVP, CLO | — | $2.76M |
| 2 | Guyer Charles Greg | EVP, Chief Technical Off | — | $996.7K |
| 3 | Friberg Gregory R | EVP, Chief R, D Off | — | $558.6K |
| 4 | Ramchandani Rashmi Virendra | VP, CAO | — | — |
| 5 | Hubbard Cristin | EVP, Chief Commercial Off | — | — |
| 6 | Hardy Alexander | CEO, Dir | — | — |
| 7 | Plenge Robert M | Dir | — | — |
| 8 | ANDERSON ELIZABETH M | Dir | — | — |
| 9 | Bodem Barbara W. | Dir | — | — |
| 10 | Ho Maykin | Dir | — | — |
FUCHS HENRY J made no open-market trades at BMRN in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-04-30 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $68.65 | +300 | 197.2K | +0.2% | +$20.6K | |
| 2024-09-17 | 2024-09-13 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | F - Tax | $84.90 | -12.1K | 185.1K | -6% | -$1.03M | |
| D | 2024-03-19 | 2024-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | F - Tax | $83.87 | -33.5K | 196.9K | -15% | -$2.81M |
| D | 2024-03-19 | 2024-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +18.2K | 230.4K | +9% | $0 |
| 2024-03-07 | 2024-03-05 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | S - Sale | $85.18 | -35.3K | 212.1K | -14% | -$3.01M | |
| M | 2024-02-29 | 2024-02-27 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +53.2K | 238.2K | +29% | $0 |
| M | 2023-12-05 | 2023-04-28+ | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $1.17 | +18.1K | 194.3K | +10% | +$21.2K |
| 2023-08-11 | 2023-08-10 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | S - Sale | $90.43 | -12.0K | 176.2K | -6% | -$1.09M | |
| DM | 2023-03-17 | 2023-03-15+ | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | F - Tax | $92.74 | -40.8K | 188.2K | -18% | -$3.78M |
| D | 2023-03-17 | 2023-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +16.8K | 229.0K | +8% | $0 |
| M | 2023-03-02 | 2023-02-28 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +68.1K | 198.8K | +52% | $0 |
| D | 2022-03-17 | 2022-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +38.8K | 158.1K | +33% | $0 |
| DM | 2022-03-17 | 2022-03-15+ | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | F - Tax | $78.66 | -14.4K | 146.0K | -9% | -$1.13M |
| 2022-03-10 | 2022-03-08 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $0.00 | +12.8K | 119.3K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations